Madeline Devaux

Dijon, 21000, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Impact of a Tripartite Collaboration between Oncologist, Pharmacist and Diabetologist in the Management of Patients with Diabetes Starting Chemotherapy: The ONCODIAB Trial.

Impact of a Tripartite Collaboration between Oncologist, Pharmacist and Diabetologist in the Management of Patients with Diabetes Starting Chemotherapy: The ONCODIAB Trial.

Journal: Cancers

Published: August 07, 2023

Glycemic control in people with diabetes treated with cancer chemotherapy: contribution of continuous glucose monitoring.

Glycemic control in people with diabetes treated with cancer chemotherapy: contribution of continuous glucose monitoring.

Journal: Acta diabetologica

Published: October 25, 2022

Adherence to oral anti-cancer therapies in older patients is similar to that of younger patients.

Adherence to oral anti-cancer therapies in older patients is similar to that of younger patients.

Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

Published: May 31, 2022

Clinical and Economic Impact of a Multidisciplinary Follow-Up Program in Lymphoma Patients.

Clinical and Economic Impact of a Multidisciplinary Follow-Up Program in Lymphoma Patients.

Journal: Cancers

Published: April 24, 2022

Safety of ninety-minute daratumumab infusion.

Safety of ninety-minute daratumumab infusion.

Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

Published: September 01, 2020

Clinical and economic impact of pharmacist interventions in an ambulatory hematology-oncology department.

Clinical and economic impact of pharmacist interventions in an ambulatory hematology-oncology department.

Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

Published: April 18, 2020

Retrospective evaluation of FOLFIRI3 alone or in combination with bevacizumab or aflibercept in metastatic colorectal cancer.

Retrospective evaluation of FOLFIRI3 alone or in combination with bevacizumab or aflibercept in metastatic colorectal cancer.

Journal: World journal of clinical oncology

Published: October 17, 2018

5-FU therapeutic drug monitoring as a valuable option to reduce toxicity in patients with gastrointestinal cancer.

5-FU therapeutic drug monitoring as a valuable option to reduce toxicity in patients with gastrointestinal cancer.

Journal: Oncotarget

Published: September 29, 2017

Showing 1-8 of 8

Last Updated: 09/26/2026